Eurofins Scientific Overview
- Year Founded
-
1987

- Status
-
Public
- Employees
-
62,696

- Stock Symbol
-
ERF

- Investments
-
233
- Share Price
-
$53.41
- (As of Friday Closing)
Eurofins Scientific General Information
Description
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
Contact Information
Website
www.eurofins.comCorporate Office
- Val Fleuri 23
- Luxembourg, 1526
- Luxembourg
Corporate Office
- Val Fleuri 23
- Luxembourg, 1526
- Luxembourg
Eurofins Scientific Stock Performance
As of 14-Mar-2025, Eurofins Scientific’s stock price is $53.41. Its current market cap is $9.8B with 184M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$53.41 | $54.86 | $42.18 - $67.43 | $9.8B | 184M | 398K | $2.30 |
Eurofins Scientific Financials Summary
As of 31-Dec-2024, Eurofins Scientific has a trailing 12-month revenue of $7.52B.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 13,782,412 | 13,782,412 | 16,561,087 | 17,290,388 |
Revenue | 7,521,669 | 7,521,669 | 7,049,289 | 7,057,123 |
EBITDA | 1,388,333 | 1,388,333 | 1,196,884 | 1,459,137 |
Net Income | 439,765 | 439,765 | 335,660 | 641,566 |
Total Assets | 11,330,163 | 11,330,163 | 12,036,257 | 10,813,521 |
Total Debt | 3,756,777 | 3,756,777 | 4,340,353 | 3,566,258 |
Eurofins Scientific Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Eurofins Scientific Comparisons
Industry
Financing
Details
Eurofins Scientific Competitors (13)
One of Eurofins Scientific’s 13 competitors is Merieux Nutrisciences, a Private Equity-Backed company based in Lyon, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Merieux Nutrisciences | Private Equity-Backed | Lyon, France | ||||
Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
Inotiv | Formerly PE-Backed | West Lafayette, IN | ||||
Randox | Corporation | Antrim, United Kingdom | ||||
Pharmaceutical Product Development | Formerly PE-Backed | Waltham, MA |
Eurofins Scientific Patents
Eurofins Scientific Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
FR-2834561-B1 | Method for detecting added water in products, especially food liquids | Inactive | 09-Jan-2002 | ||
FR-2834561-A1 | Process for detecting water added to products, in particular liquids for consumption such as drinks containing at least one fermentable sugar and/or ethanol | Active | 09-Jan-2002 | ||
FR-2832306-B1 | Method and device for atraumatically collecting a biological sample | Inactive | 16-Nov-2001 | ||
FR-2832306-A1 | Biological sampling process comprises taking muscle tissue from dead organisms such as animals and fish breeds, humans or plants or atraumatic sampling of fur or hair from living organisms | Active | 16-Nov-2001 | ||
DE-60104157-D1 | Method and device for confirming the absence of infectious prion proteins in meat | Inactive | 24-Mar-2000 | C12Q1/6876 |
Eurofins Scientific Signals
Eurofins Scientific Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Eurofins Scientific Investments & Acquisitions (233)
Eurofins Scientific’s most recent deal was a Merger/Acquisition with SYNLAB España. The deal was made on 28-Oct-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
SYNLAB España | 28-Oct-2024 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
FarmFacts | 10-Oct-2024 | Merger/Acquisition | Other Commercial Services | ||
Infinity Laboratories | 16-Sep-2024 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
Verdelab Bioscience | 12-Sep-2024 | Merger/Acquisition | Other Commercial Services | ||
Orchid Cellmark | 20-Aug-2024 | Merger/Acquisition | Laboratory Services (Healthcare) |
Eurofins Scientific ESG
Risk Overview
Risk Rating
Updated July, 23, 2024
15.15 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,946
Rank
Percentile

Pharmaceuticals
Industry
of 847
Rank
Percentile

Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile

Eurofins Scientific Exits (4)
Eurofins Scientific’s most recent exit was on 01-Nov-2014 from Resillion. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Resillion | 01-Nov-2014 | Completed |
|
||
Eurofins Lancaster Laboratories | 04-Apr-2011 | Completed |
|
||
Laboratoire de Rouen | 24-Jan-2011 | Completed |
|
||
GfA Gesellschaft fuer Aerophysik | 24-Jan-2001 | Merger/Acquisition | Completed |
Eurofins Scientific Affiliates
Subsidiaries (72)
Name | Industry | Location | Year Founded |
---|---|---|---|
Eurofins CRA | Cheongju-si, South Korea | 2019 | |
DIA-Go | Amsterdam, Netherlands | 2018 | |
bestLab | Helsinki, Finland | 2016 | |
Repertoire Genesis | Tokyo, Japan | 2014 | |
Transplant Genomics | Framingham, MA | 2013 |
Eurofins Scientific FAQs
-
When was Eurofins Scientific founded?
Eurofins Scientific was founded in 1987.
-
Where is Eurofins Scientific headquartered?
Eurofins Scientific is headquartered in Luxembourg, Luxembourg.
-
What is the size of Eurofins Scientific?
Eurofins Scientific has 62,696 total employees.
-
What industry is Eurofins Scientific in?
Eurofins Scientific’s primary industry is Laboratory Services (Healthcare).
-
Is Eurofins Scientific a private or public company?
Eurofins Scientific is a Public company.
-
What is Eurofins Scientific’s stock symbol?
The ticker symbol for Eurofins Scientific is ERF.
-
What is the current stock price of Eurofins Scientific?
As of 14-Mar-2025 the stock price of Eurofins Scientific is $53.41.
-
What is the current market cap of Eurofins Scientific?
The current market capitalization of Eurofins Scientific is $9.8B.
-
What is Eurofins Scientific’s current revenue?
The trailing twelve month revenue for Eurofins Scientific is $7.52B.
-
Who are Eurofins Scientific’s competitors?
Merieux Nutrisciences, Charles River Laboratories International, Inotiv, Randox, and Pharmaceutical Product Development are some of the 13 competitors of Eurofins Scientific.
-
What is Eurofins Scientific’s annual earnings per share (EPS)?
Eurofins Scientific’s EPS for 12 months was $2.30.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »